CR GROUP L.P. reported 2 transactions at T2 BIOSYSTEMS, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 5/13/2024ACC: 0001415889-24-013055
+1.80M
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
4
Total transactions
1.82M acquired · 28.04K disposed
Non-Derivative Transactions2
Common Stock
Indirect
Shares
+1.72M
Price / share
—
Trade value
—
% of position
59.6%
5/9/2024
2.88M→4.60M
Common Stock
Indirect
Shares
+108.75K
Price / share
—
Trade value
—
% of position
2.4%
5/9/2024
4.60M→4.70M
Total
Net shares
+1.82M
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 5/9/2024 | C · Conversion | +1.72M | — | — | 59.6% | 2.88M | 4.60M |
| Common Stock Indirect | 5/9/2024 | C · Conversion | +108.75K | — | — | 2.4% | 4.60M | 4.70M |
| Total | +1.82M | $0.00 | ||||||
Derivative Transactions2
Series A Preferred Stock
Indirect
Converts to
Common Stock
1.72M shares
Shares
−17.16K
Strike price
Held after
0.00
Exercisable
—
5/9/2024
Series B Preferred Stock
Indirect
Converts to
Common Stock
108.75K shares
Shares
−10.88K
Strike price
Held after
0.00
Exercisable
—
5/9/2024
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Series A Preferred Stock Indirect | Common Stock1.72M shares | 5/9/2024 | C · Conversion | −17.16K | — | 0.00 | |
| Series B Preferred Stock Indirect | Common Stock108.75K shares | 5/9/2024 | C · Conversion | −10.88K | — | 0.00 |